Variables predicting clinical remission among adults with severe asthma treated with biologic agents

Conclusions. Omalizumab and mepolizumab provide significant clinical remission rates in severe asthma. FEV1% predicted is a variable that can independently predict clinical remission among severe asthmatics receiving biologic agents.PMID:38054608 | DOI:10.23822/EurAnnACI.1764-1489.318

Source: European Annals of Allergy and Clinical Immunology - December 6, 2023 Category: Allergy & Immunology Authors: S Ye şilkaya K Aksu G Tu ğçe Vural Solak O Akkale O Telli H C Tu ğlu G K öycü Buhari S N Bah çecioğlu S Demir Source Type: research